FDA seeks a hazard and risk assessment protocol for evaluating the safety of cosmetic ingredients, according to a recently issued contract solicitation notice, which could signal preparations being made for regulatory updates proposed by Congress.
Posted Aug
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?